🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/10/2024 | 109,49 | 110,30 | 109,39 | 109,77 | -0,37% | 0,83% | 9.704.700 |
| 03/10/2024 | 111,82 | 112,08 | 109,83 | 110,18 | -1,70% | 2,01% | 10.280.600 |
| 02/10/2024 | 114,55 | 114,60 | 111,98 | 112,08 | -2,32% | 2,29% | 9.041.800 |
| 01/10/2024 | 113,96 | 114,79 | 113,11 | 114,74 | +1,04% | 1,47% | 7.715.500 |
| 30/09/2024 | 113,61 | 114,01 | 112,70 | 113,56 | -0,11% | 1,15% | 10.936.900 |
| 27/09/2024 | 113,17 | 114,34 | 113,00 | 113,69 | +0,53% | 1,18% | 11.920.100 |
| 26/09/2024 | 113,88 | 114,00 | 112,93 | 113,09 | -1,43% | 0,94% | 11.132.100 |
| 25/09/2024 | 115,30 | 116,02 | 114,62 | 114,73 | -0,20% | 1,21% | 7.902.300 |
| 24/09/2024 | 115,85 | 116,26 | 114,32 | 114,96 | -0,58% | 1,67% | 9.840.400 |
| 23/09/2024 | 117,20 | 118,16 | 115,52 | 115,63 | -1,31% | 2,25% | 6.665.300 |
| 20/09/2024 | 117,27 | 117,50 | 116,41 | 117,17 | -0,05% | 0,93% | 21.200.900 |
| 19/09/2024 | 118,90 | 119,20 | 116,29 | 117,23 | -1,19% | 2,45% | 9.963.000 |
| 18/09/2024 | 118,20 | 119,38 | 117,87 | 118,64 | +0,30% | 1,28% | 11.135.600 |
| 17/09/2024 | 118,97 | 119,14 | 117,73 | 118,29 | +0,28% | 1,19% | 7.914.900 |
| 16/09/2024 | 115,80 | 118,37 | 115,80 | 117,96 | +1,81% | 2,22% | 7.846.100 |
| 13/09/2024 | 116,09 | 116,77 | 115,00 | 115,86 | +0,53% | 1,52% | 6.709.600 |
| 12/09/2024 | 114,47 | 115,51 | 114,04 | 115,25 | +0,47% | 1,28% | 8.330.900 |
| 11/09/2024 | 114,94 | 115,89 | 114,27 | 114,71 | -0,54% | 1,41% | 7.836.600 |
| 10/09/2024 | 115,21 | 116,09 | 113,33 | 115,33 | -0,07% | 2,40% | 12.734.500 |
| 09/09/2024 | 113,15 | 116,90 | 112,41 | 115,41 | -2,06% | 3,97% | 14.880.200 |
| 06/09/2024 | 119,10 | 120,30 | 117,65 | 117,84 | -0,63% | 2,23% | 8.577.300 |
| 05/09/2024 | 116,61 | 120,07 | 116,35 | 118,59 | +2,41% | 3,19% | 12.009.700 |
| 04/09/2024 | 116,66 | 116,73 | 114,47 | 115,80 | -0,67% | 1,94% | 7.693.400 |
| 03/09/2024 | 118,26 | 118,84 | 116,42 | 116,58 | -1,58% | 2,05% | 7.640.300 |
| 30/08/2024 | 117,27 | 118,75 | 117,15 | 118,45 | +0,84% | 1,36% | 8.876.500 |
| 29/08/2024 | 117,93 | 118,40 | 116,79 | 117,46 | +0,05% | 1,37% | 7.202.500 |
| 28/08/2024 | 116,60 | 118,02 | 116,24 | 117,40 | +0,77% | 1,53% | 5.403.200 |
| 27/08/2024 | 116,27 | 116,62 | 115,25 | 116,50 | +0,20% | 1,18% | 5.502.600 |
| 26/08/2024 | 116,73 | 117,90 | 116,16 | 116,27 | -0,28% | 1,49% | 6.518.700 |
| 23/08/2024 | 116,80 | 116,81 | 115,92 | 116,60 | +0,04% | 0,76% | 8.368.200 |